|
1
|
Insull W Jr: The pathology of
atherosclerosis: Plaque development and plaque responses to medical
treatment. Am J Med. 122(Suppl1): S3–S14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rudijanto A: The role of vascular smooth
muscle cells on the pathogenesis of atherosclerosis. Acta Med
Indones. 39:86–93. 2007.PubMed/NCBI
|
|
3
|
Al Ghouleh I, Khoo NK, Knaus UG,
Griendling KK, Touyz RM, Thannickal VJ, Barchowsky A, Nauseef WM,
Kelley EE, Bauer PM, et al: Oxidases and peroxidases in
cardiovascular and lung disease: New concepts in reactive oxygen
species signaling. Free Radic Biol Med. 51:1271–1288. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Csányi G, Taylor WR and Pagano PJ: NOX and
inflammation in the vascular adventitia. Free Radic Biol Med.
47:1254–1266. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Clempus RE and Griendling KK: Reactive
oxygen species signaling in vascular smooth muscle cells.
Cardiovasc Res. 71:216–225. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Banno N, Akihisa T, Tokuda H, Yasukawa K,
Higashihara H, Ukiya M, Watanabe K, Kimura Y, Hasegawa J and
Nishino H: Triterpene acids from the leaves of Perilla frutescens
and their anti-inflammatory and antitumor-promoting effects. Biosci
Biotechnol Biochem. 68:85–90. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park GH, Lee JY, Kim DH, Cho YJ and An BJ:
Anti-oxidant and antiinflammatory effects of Rosa multiform root. J
Life Sci. 21:1120–1126. 2011. View Article : Google Scholar
|
|
8
|
Bortalanza LB, Ferreira J, Hess SC, Delle
Monache F, Yunes RA and Calixto JB: Anti-allodynic action of the
tormentic acid, a triterpene isolated from plant, against
neuropathic and inflammatory persistent pain in mice. Eur J
Pharmacol. 453:203–208. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ivorra M, Paya M and Villar A:
Hypoglycemic and insulin release effects of tormentic acid: A new
hypoglycemic natural product. Planta Med. 54:282–285. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu JB, Kuo YH, Lin CH, Ho HY and Shih CC:
Tormentic acid, a major component of suspension cells of Eriobotrya
japonica, suppresses high-fat diet-induced diabetes and
hyperlipidemia by glucose transporter 4 and AMP-activated protein
kinase phosphorylation. J Agric Food Chem. 62:10717–10726. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fogo AS, Antonioli E, Calixto JB and
Campos AH: Tormentic acid reduces vascular smooth muscle cell
proliferation and survival. Eur J Pharmacol. 615:50–54. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
An HJ, Kim IT, Park HJ, Kim HM, Choi JH
and Lee KT: Tormentic acid, a triterpenoid saponin, isolated from
Rosa rugosa, inhibited LPS-induced iNOS, COX-2, and TNF-α
expression through inactivation of the nuclear factor-κb pathway in
RAW 264.7 macrophages. Int Immunopharmacol. 11:504–510. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chamley-Campbell J, Campbell GR and Ross
R: The smooth muscle cell in culture. Physiol Rev. 59:1–61.
1979.PubMed/NCBI
|
|
14
|
Parthasarathy S, Khan-Merchant N,
Penumetcha M and Santanam N: Oxidative stress in cardiovascular
disease. J Nucl Cardiol. 8:379–389. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harrison D, Griendling KK, Landmesser U,
Hornig B and Drexler H: Role of oxidative stress in
atherosclerosis. Am J Cardiol. 91:7A–11A. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Torres M and Forman HJ: Redox signaling
and the MAP kinase pathways. Biofactors. 17:287–296. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Griendling KK, Sorescu D, Lassègue B and
Ushio-Fukai M: Modulation of protein kinase activity and gene
expression by reactive oxygen species and their role in vascular
physiology and pathophysiology. Arterioscler Thromb Vasc Biol.
20:2175–2183. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Taniyama Y and Griendling KK: Reactive
oxygen species in the vasculature: Molecular and cellular
mechanisms. Hypertension. 42:1075–1081. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Detmers PA, Hernandez M, Mudgett J,
Hassing H, Burton C, Mundt S, Chun S, Fletcher D, Card DJ, Lisnock
J, et al: Deficiency in inducible nitric oxide synthase results in
reduced atherosclerosis in apolipoprotein E-deficient mice. J
Immunol. 165:3430–3435. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bedard K and Krause KH: The NOX family of
ROS-generating NAPDH oxidase: Physiology and pathophysiology.
Physiol Rev. 87:245–313. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sheehan AL, Carrell S, Johnson B, Stanic
B, Banfi B and Miller FJ Jr: Role for Nox1 NADPH oxidase in
atherosclerosis. Atherosclerosis. 216:321–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dikalova AE, Góngora MC, Harrison DG,
Lambeth JD, Dikalov S and Griendling KK: Upregulation of Nox1 in
vascular smooth muscle leads to impaired endothelium-dependent
relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol.
299:H673–H679. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barry-Lane PA, Patterson C, van der Merwe
M, Hu Z, Holland SM, Yeh ET and Runge MS: p47phox is required for
atherosclerotic lesion progression in ApoE(−/−) mice. J Clin
Invest. 108:1513–1522. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li WG, Miller FJ Jr, Zhang HJ, Spitz DR,
Oberley LW and Weintraub NL: H(2)O(2)-induced O(2) production by a
non-phagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem.
276:29251–29256. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Libby P, Ridker PM and Maseri A:
Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li D, Fu Y, Zhang W, Su G, Liu B, Guo M,
Li F, Liang D, Liu Z, Zhang X, et al: Salidroside attenuates
inflammatory responses by suppressing nuclear factor-κB and mitogen
activated protein kinases activation in lipopolysaccharide-induced
mastitis in mice. Inflamm Res. 62:9–15. 2013. View Article : Google Scholar
|
|
27
|
Dinarello C: The IL-1 family and
inflammatory diseases. Clin Exp Rheumatol. 20(5 Suppl 27): S1–S13.
2002.
|
|
28
|
O'Brien KD, McDonald TO, Chait A, Allen MD
and Alpers CE: Neovascular expression of E-selectin, intercellular
adhesion molecule-1 and vascular cell adhesion molecule-1 in human
atherosclerosis and their relation to intimal leukocyte content.
Circulation. 93:672–682. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Barnes PJ and Karin M: Nuclear
factor-kappaB: A pivotal transcription factor in chronic
inflammatory disease. N Engl J Med. 336:1066–1071. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tumur Z, Shimizu H, Enomoto A, Miyazaki H
and Niwa T: Indoxyl sulfate upregulates expression of ICAM-1 and
MCP-1 by oxidative stress-induced NF-kappaB activation. Am J
Nephrol. 31:435–441. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pierce GL, Lesniewski LA, Lawson BR, Beske
SD and Seals DR: Nuclear factor-{kappa}B activation contributes to
vascular endothelial dysfunction via oxidative stress in
overweight/obese middle-aged and older humans. Circulation.
119:1284–1292. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sprague AH and Khalil RA: Inflammatory
cytokines in vascular dysfunction and vascular disease. Biochem
Pharmacol. 78:539–552. 2009. View Article : Google Scholar : PubMed/NCBI
|
